ANI Pharmaceuticals beat analysts’ revenue expectations by 10.4% last quarter, reporting revenues of $211.4 million, up 53.1% ...
A new formulation of the Envita bacterium distributed by Syngenta is expected to help farmers tap into more of the nitrogen ...
With a diverse portfolio of 116 pharmaceutical products and a growing rare disease platform, ANI Pharmaceuticals (NASDAQ:ANIP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback